CSF3 and Stroke: The elevation of leukocytes, intrinsic to G-CSF treatment, may potentially lead to endothelial and blood coagulation activation causing a plugging of the microvasculature close to the infarction with an increased risk for thromboembolic events in stroke patients [13].